The University of Maryland, Baltimore (UMB) Institute for Clinical and Translational Research (ICTR) is delighted to share a compelling story featuring the work of Kristen Coleman, PhD, our 2023 UMB/University of Maryland, College Park (UMCP) KL2 scholar, whose pioneering research is supported by the ICTR’s prestigious KL2 Mentored Career Development Award. Recently highlighted in a prominent news piece by Business Insider, Coleman's work exemplifies the impactful contributions of ICTR scholars to the field of clinical research.
The story centers around Christopher Silva, a participant in clinical trials focused on dysentery and influenza transmission. Silva's involvement not only helps to advance scientific understanding, but his detailed, personal accounting also highlights the benefits participants report from their experience with clinical research.
The UMB ICTR takes immense pride in supporting innovative research endeavors aimed at addressing pressing health challenges. Coleman's research, made possible by the UMB ICTR KL2 award, underscores our commitment to fostering translational research that directly impacts patient care and public health outcomes.
For more details, read the Business Insider story here.
Stay tuned for further updates on the groundbreaking research initiatives happening at UMB ICTR. Visit our ICTR website and subscribe to our newsletter for the latest updates and upcoming events.